Article
Mdr1 gene expression and mutations in Ras proto-oncogenes in acute myeloid leukemia.
Leukemia & lymphoma - 1 Jul 2002
Schaich Markus, Illmer Thomas
Abstract excerpt
Resistance to cytotoxic therapy and development of refractory disease in acute myeloid leukemia (AML) is frequently associated with the expression of mdr1/P-gp. In the last years many potential signaling pathways leading to modulation of mdr1 expression have been described. Thus, it has been assumed that activated Ras may influence mdr1 expression. This activation can be realized by mutations in the Ras oncogene...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
